Skip to main content

Table 3 Mapping of targeted signaling pathways on canonical oncogenic pathways based on related cancer pathophysiologic processes

From: A systems pharmacology approach based on oncogenic signalling pathways to determine the mechanisms of action of natural products in breast cancer from transcriptome data

Drug

Carcinogenesis process

Cell Line

Activity

Cell cycle/Proliferation and Apoptosis

Metastasis and invasion

Angiogenesis

ACT

MDA-MB- 453

Down

Intrinsic Pathway for Apoptosis

PTK6 Regulates Cell Cycle

Interferon Signaling

–

–

Up

PI3K-Akt-mTOR

NRF2 pathway

TGF-beta Signaling Pathway

–

–

CKI

MCF-7

Down

p53 signaling pathway

regulation of intrinsic apoptotic signaling pathway

–

–

Up

PI3K-AKT-mTOR signaling pathway and therapeutic opportunities

EGF/EGFR Signaling Pathway

NRF2 pathway

Fc epsilon RI signaling pathway

T cell receptor signaling pathway

B cell receptor signaling pathway

Canonical and Non-Canonical TGF-B signaling

VEGFA-VEGFR2 Signaling Pathway

WA

MCF-7

Down

p53 signaling pathway

NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and − 10

Interferon Signaling

Cytokine Signaling in Immune system

–

TGF-beta Signaling Pathway

Up

NRF2 pathway

MAPK Signaling Pathway

p53 signaling pathway

intrinsic apoptotic signaling pathway

–

–

MDA-MB-231

Down

NRF2 pathway

MAPK signaling pathway

ErbB Signaling Pathway

p53 signaling pathway

TGF-beta Signaling Pathway

Notch Signaling Pathway

IL-4 Signaling Pathway

IL17 signaling pathway

TCF dependent signaling in response to WNT

–

Up

PI3K-Akt Signaling Pathway

Interferon Signaling

TNF signaling pathway

Inflammatory Response Pathway

VEGFA-VEGFR2 Signaling Pathway

Notch (U)

TGF-beta Signaling Pathway

I3C

MCF-7

Down

TP53 Regulates Transcription of Cell Cycle Genes

Signaling by EGFR

Apoptosis

PI3K-AKT-mTOR signaling pathway and therapeutic opportunities

MAPK Signaling Pathway

Wnt Signaling Pathway and Pluripotency

T-Cell Receptor and Co-stimulatory Signaling

TNF alpha Signaling Pathway

TGF-beta Receptor Signaling

–

Up

Apoptosis

regulation of cell cycle

–

–

T47D

Down

Cell Cycle, Mitotic

ErbB Signaling Pathway

PI3K-Akt Signaling Pathway

Chemokine signaling pathway

Signaling by NOTCH1 in Cancer

Wnt Signaling Pathway and Pluripotency

TGF-beta Signaling Pathway

VEGFA-VEGFR2 Signaling Pathway

PDGF Pathway

Up

RIG-I-like Receptor Signaling

Apoptosis

MAPK Signaling Pathway

Interferon gamma signaling

TGF-beta Signaling Pathway

–

–

ZR751

Down

EGF/EGFR Signaling Pathway

Notch Signaling Pathway

TGF-beta Signaling Pathway

regulation of apoptotic process

Negative regulators of RIG-I/MDA5 signaling

Wnt Signaling Pathway and Pluripotency

VEGFA-VEGFR2 Signaling Pathway

Up

Interferon Signaling

NRF2 pathway

Apoptosis

MAPK Signaling Pathway

–

–

MDA-MB-231

Down

–

Pathways Regulating Hippo Signaling

VEGFA-VEGFR2 Signaling Pathway

Up

NRF2 pathway

–

–

MDA-MB-436

Down

ErbB Signaling Pathway

PI3K-Akt Signaling Pathway

MAPK Signaling Pathway

Wnt Signaling Pathway and Pluripotency

Hippo(D)

T-Cell Receptor and Co-stimulatory Signaling

PDGF(D)

TGF-beta Signaling Pathway

Up

Apoptosis-related network due to altered Notch3 in ovarian cancer

TGF-beta Signaling Pathway

Activated TLR4 signalling

–

–

  1. Three major oncological processes defining the diverse molecular processes associated with carcinogenesis were used to deduce biological roles of the various enriched oncological signaling pathways